Company / EPS (Diluted)
Neogen EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.12
FY2025
5-year range
-$0.12 / $0.57
FY2021-FY2025
Trend
-126.7%
vs FY2024
Sector context
#97 of 159
Health Care
What the data says
At $-0.12, Neogen's eps (diluted) ranks #97 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.12 in FY2025 to $1.21 in FY2020.
Based on SEC 10-K filings.
-0.12 in FY2025.
Declined from $0.57 to $-0.12 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 159 in Health CareTop 61% of 159This company -$0.12 Sector average $1.66
▼
-107.3% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 126.7% year-over-year.
- Ranks #97 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.12 | -126.7% |
| FY2024 | $0.45 | -21.1% |
| FY2023 | $0.57 | +1.8% |
| FY2022 | $0.56 | -1.8% |
| FY2021 | $0.57 | -52.9% |
| FY2020 | $1.21 | +40.7% |
| FY2019 | $0.86 | +19.4% |
| FY2018 | $0.72 | -20.0% |
| FY2017 | $0.90 | +18.4% |
| FY2016 | $0.76 | +1.3% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026